In the BioHarmony Drug Report Database
Naratriptan
Amerge (naratriptan) is a small molecule pharmaceutical. Naratriptan was first approved as Amerge on 1998-02-10. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1F, and 5-hydroxytryptamine receptor 1A.
Trade Name
|
Amerge |
|---|---|
Common Name
|
naratriptan |
ChEMBL ID
|
CHEMBL1278 |
Indication
|
migraine disorders |
Drug Class
|
Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives |
Image (chem structure or protein)